1stmd anderson international meeting in gastrointestinal … md... · 2019. 7. 16. · advanced...

12
Registrations: www.mdanderson.es/gastrointestinaloncology @MDAnderson_ES Madrid, 29 th November - 1 st December, 2017 Dr. Santiago González-Moreno · MD Anderson Cancer Center Madrid, Spain Dr. Miguel A. Rodriguez-Bigas · The University of Texas MD Anderson Cancer Center, Houston, USA Meeting Directors: Oncology Gastrointestinal MD ANDERSON INTERNATIONAL MEETING IN CURRENT PRACTICE AND CONTROVERSIES 1 st in the E ra ra o o f f Pe Pe rs s on on al al iz iz ed ed M Med i c in e SCIENTIFIC PROGRAM

Upload: others

Post on 22-Aug-2020

0 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: 1stMD ANDERSON INTERNATIONAL MEETING IN Gastrointestinal … MD... · 2019. 7. 16. · advanced gastric cancer: perioperative chemotherapy versus postoperative chemoradiotherapy Dr

Registrations: www.mdanderson.es/gastrointestinaloncology @MDAnderson_ES

Madrid, 29th November - 1st December, 2017

Dr. Santiago González-Moreno · MD Anderson Cancer Center Madrid, SpainDr. Miguel A. Rodriguez-Bigas · The University of Texas MD Anderson Cancer Center, Houston, USA

Meeting Directors:

OncologyGastrointestinal

MD ANDERSON INTERNATIONAL MEETING IN

CURRENT PRACTICE AND CONTROVERSIES

1st

in the Erara ooff PePerssononalalizizeded MMedicine

SCIEN

TIFIC PRO

GRA

M

Page 2: 1stMD ANDERSON INTERNATIONAL MEETING IN Gastrointestinal … MD... · 2019. 7. 16. · advanced gastric cancer: perioperative chemotherapy versus postoperative chemoradiotherapy Dr

SCIENTIFIC COMMITTEE

Surgical OncologyDr. Oscar AlonsoDr. Gloria Ortega

PathologyDr. Alejandro Rojo

GastroenterologyDr. Mercedes García-Casas

Dr. José Luis Calleja

Clinical TrialsMrs. Marta Gutiérrez

Scientific Commitee CoordinatorsDr. Santiago González-MorenoDr. Miguel A. Rodríguez-Bigas

Medical OncologyDr. Ignacio JuezDr. Sara Encinas

Radiation OncologyDr. Cristina Garrán

Diagnostic ImagingDr. Raquel Saiz

Dr. Juan Carlos Alonso

The 1st MD Anderson International Meeting in Gastrointestinal Oncology: Current Practice and Controversies in the Era of Personalized Medicine, Madrid, Spain, 29/11/2017-01/12/2017 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 14 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at www.ama-assn.org/go/internationalcme.

Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.

The EACCME® awards ECMEC®s on the basis of 1 ECMEC® for one hour of CME with a maximum of 8 ECMEC®s per day. Please find the breakdown of ECMEC®s per day: November 29th– 3; November 30th– 7; December 1st– 4.

Application for CME credits has been forwarded to the Spanish Accreditation Council for Continuing Medical Education. Currently pending of resolution.

With the collaboration of the Educational Committee of the MD Anderson Cancer Center Madrid.

Accreditation

Page 3: 1stMD ANDERSON INTERNATIONAL MEETING IN Gastrointestinal … MD... · 2019. 7. 16. · advanced gastric cancer: perioperative chemotherapy versus postoperative chemoradiotherapy Dr

16:00 - 16:15 WELCOME REMARKS Dr. Santiago González-Moreno MD Anderson Cancer Center Madrid, Spain Dr. Miguel A. Rodríguez-Bigas The University of Texas MD Anderson Cancer Center, Houston, USA

PANCREATIC CANCER

16:15 - 17:45 MULTIDISCIPLINARY SCIENTIFIC SYMPOSIUM Pancreatic Neoplasms: from cystic to metastatic cancer

Moderators: Dr. José Manuel Ramia-Ángel Hospital Universitario de Guadalajara, Spain Dr. Alfredo Carrato Hospital Univ. Ramón y Cajal, Madrid, Spain

16:15 - 16:35 Cystic neoplasms of the pancreas Dr. Francis R. Spitz MD Anderson Cancer Center at Cooper, Camden, USA

16:35 - 16:55 Neoadjuvant therapy in pancreas adenocarcinoma. When is it necessary? Dr. Ching-Wei D. Tzeng The University of Texas MD Anderson Cancer Center, Houston, USA

16:55 - 17:15 Systemic therapy for metastatic pancreas adenocarcinoma. New trends Dr. Milind Javle The University of Texas MD Anderson Cancer Center, Houston, USA

17:15 - 17:45 Discussion

17:45 - 18:15 KEYNOTE LECTURE

17:45 - 18:05 Evolution of surgery for pancreatic cancer Dr. Jeffrey E. Lee The University of Texas MD Anderson Cancer Center, Houston, USA

18:05 - 18:15 Discussion

18:15 - 18:45 Coffee break

Wednesday, N

ovember 29

th, 2017

Page 4: 1stMD ANDERSON INTERNATIONAL MEETING IN Gastrointestinal … MD... · 2019. 7. 16. · advanced gastric cancer: perioperative chemotherapy versus postoperative chemoradiotherapy Dr

Wed

nesd

ay, N

ovem

ber 2

9th, 2

017

18:45 - 19:30 DEBATE Arterial resection is indicated in surgery for locally advanced pancreatic cancer

Moderator: Dr. Oscar Alonso MD Anderson Cancer Center Madrid, Spain

18:45 - 18:55 Introduction and voting

18:55 - 19:05 Pro Dr. Ching-Wei D. Tzeng The University of Texas MD Anderson Cancer Center, Houston, USA

19:05 - 19:15 Against Dr. Francis R. Spitz MD Anderson Cancer Center at Cooper, Camden, USA

19:15 - 19:25 Discussion

19:25 - 19:30 Voting after debate

19:30 - 20:30 MULTIDISCIPLINARY TUMOR BOARD Moderator: Dr. José Manuel Ramia-Ángel Hospital Universitario de Guadalajara, Spain

PANEL:Medical Oncology Dr. Alfredo Carrato

Hospital Univ. Ramón y Cajal, Madrid, SpainRadiology Dr. Raquel Saiz

MD Anderson Cancer Center Madrid, SpainSurgical Oncology Dr. Ching-Wei D. Tzeng

The University of Texas MD Anderson Cancer Center, Houston, USASurgical Oncology Dr. Claudius Conrad

The University of Texas MD Anderson Cancer Center, Houston, USAMedical Oncology Dr. Milind Javle

The University of Texas MD Anderson Cancer Center, Houston, USA

PRESENTERS:

19:30 - 19:50 HBP clinical case 1: Cystic neoplasm of the pancreas

19:50 - 20:10 HBP clinical case 2: Borderline resectable pancreatic cancer

20:10 - 20:30 HBP clinical case 3: Unresectable intrahepatic cholangiocarcinoma

Page 5: 1stMD ANDERSON INTERNATIONAL MEETING IN Gastrointestinal … MD... · 2019. 7. 16. · advanced gastric cancer: perioperative chemotherapy versus postoperative chemoradiotherapy Dr

Thursday, N

ovember 30

th, 2017

COLORECTAL CANCER

08:30 - 10:00 MULTIDISCIPLINARY SCIENTIFIC SYMPOSIUM What’s new in multidisciplinary management of colorectal cancer?

Moderators: Dr. Yi-Qian Nancy You The University of Texas MD Anderson Cancer Center, Houston, USA Dr. Sara Encinas MD Anderson Cancer Center Madrid, Spain

08:30 - 08:50 Neoadjuvant and adyuvant therapy in rectal adenocarcinoma. Is the paradigm changing? Dr. Carlos Fernández Martos Fundación Instituto Valenciano de Oncología - FIVO, Valencia, Spain

08:50 - 09:10 Radiation in mid rectal cancer. In or out? Dr. Bruce D. Minsky The University of Texas MD Anderson Cancer Center, Houston, USA

09:10 - 09:30 Systemic therapy for metastatic colorectal cancer. New trends Dr. Cathy Eng The University of Texas MD Anderson Cancer Center, Houston, USA

09:30 - 10:00 Discussion

10:00 - 10:30 PATIENT ADVOCATES’ LECTURE

10:00 - 10:20 What do patients expect from our gastrointestinal oncology doctors? Mrs. Jola Gore-Booth President of Europa Colon

10:20 - 10:30 Questions

10:30 - 11:00 Coffee break

Page 6: 1stMD ANDERSON INTERNATIONAL MEETING IN Gastrointestinal … MD... · 2019. 7. 16. · advanced gastric cancer: perioperative chemotherapy versus postoperative chemoradiotherapy Dr

11:00 - 11:45 DEBATE Observation is indicated after complete clinical response to neoadjuvant therapy in rectal cancer

Moderator: Dr. Miguel A. Rodríguez-Bigas

The University of Texas MD Anderson Cancer Center, Houston, USA

11:00 - 11:10 Introduction and voting

11:10 - 11:20 Pro Dr. Damián García Olmo Hospital Univ. Fundación Jiménez Díaz, Madrid, Spain

11:20 - 11:30 Against Dr. Yi-Qian Nancy You The University of Texas MD Anderson Cancer Center, Houston, USA

11:30 - 11:40 Discussion

11:40 - 11:45 Voting after debate

11:45 - 13:00 MULTIDISCIPLINARY TUMOR BOARD Moderator: Dr. Damián García Olmo

Hospital Univ. Fundación Jiménez Díaz, Madrid, Spain

PANEL:Medical Oncology Dr. Cathy Eng

The University of Texas MD Anderson Cancer Center, Houston, USASurgical Oncology Dr. Yi-Qian Nancy You

The University of Texas MD Anderson Cancer Center, Houston, USARadiology Dr. Raquel Saiz

MD Anderson Cancer Center Madrid, SpainRadiation Oncology Dr. Bruce D. Minsky

The University of Texas MD Anderson Cancer Center, Houston, USAPathology Dr. Juan Fernando García García

MD Anderson Cancer Center Madrid, Spain

PRESENTERS:

11:45 - 12:10 Colorectal clinical case 1: High grade neuroendocrine rectal cancer

12:10 - 12:35 Colorectal clinical case 2: Mid rectal cancer with internal iliac lymph nodes or mid rectal cancer T3N0

12:35 - 13:00 Colorectal clinical case 3: Local recurrence of rectal cancer. Pelvic exenteration

13:00 - 14:30 Lunch

Thur

sday

, Nov

embe

r 30th

, 201

7

Page 7: 1stMD ANDERSON INTERNATIONAL MEETING IN Gastrointestinal … MD... · 2019. 7. 16. · advanced gastric cancer: perioperative chemotherapy versus postoperative chemoradiotherapy Dr

MULTIDISCIPLINARY APPROACH TO METASTATIC DISEASE

14:30 - 16:00 MULTIDISCIPLINARY SCIENTIFIC SYMPOSIUM No lung-no liver colorectal metastatic disease

Moderators: Dr. Sara Encinas

MD Anderson Cancer Center Madrid, Spain Dr. Cristina Garrán

MD Anderson Cancer Center Madrid, Spain

14:30 - 14:50 Re-irradiation in GI malignancies. Where, when, and how? Dr. Bruce D. Minsky

The University of Texas MD Anderson Cancer Center, Houston, USA

14:50 - 15:10 Management of metastatic retroperitoneal lymphadenopathy in colorectal cancer

Dr. Miguel A. Rodríguez-Bigas The University of Texas MD Anderson Cancer Center, Houston, USA

15:10 - 15:30 Present and future of colorectal carcinomatosis Dr. Santiago González-Moreno

MD Anderson Cancer Center Madrid, Spain

15:30 - 16:00 Discussion

16:00 - 16:30 KEYNOTE LECTURE

16:00 - 16:20 Management of hepatic metastases from colorectal cancer. Pushing the limit

Dr. Claudius Conrad The University of Texas MD Anderson Cancer Center, Houston, USA

16:20 - 16:30 Discussion

16:30 - 17:00 Coffee break

Thursday, N

ovember 30

th, 2017

Page 8: 1stMD ANDERSON INTERNATIONAL MEETING IN Gastrointestinal … MD... · 2019. 7. 16. · advanced gastric cancer: perioperative chemotherapy versus postoperative chemoradiotherapy Dr

17:00 - 18:30 MULTIDISCIPLINARY TUMOR BOARD Moderator: Dr. Gloria Ortega

MD Anderson Cancer Center Madrid, Spain

PANEL: Surgical Oncology Dr. Miguel A. Rodríguez-Bigas

The University of Texas MD Anderson Cancer Center, Houston, USASurgical Oncology Dr. Oscar Alonso

MD Anderson Cancer Center Madrid, SpainMedical Oncology Dr. Cathy Eng

The University of Texas MD Anderson Cancer Center, Houston, USASurgical Oncology Dr. Claudius Conrad

The University of Texas MD Anderson Cancer Center, Houston, USARadiation Oncology Dr. Bruce D. Minsky

The University of Texas MD Anderson Cancer Center, Houston, USA

PRESENTERS:

17:00 - 17:30 Metastatic disease clinical case 1: Colorectal liver metastases and carcinomatosis

17:30 - 18:00 Metastatic disease clinical case 2: Resectable liver metastases and unresectable lung metastases

18:00 - 18:30 Metastatic disease clinical case 3: Unresectable liver converted to resectable with missing metastases

Thur

sday

, Nov

embe

r 30th

, 201

7

Page 9: 1stMD ANDERSON INTERNATIONAL MEETING IN Gastrointestinal … MD... · 2019. 7. 16. · advanced gastric cancer: perioperative chemotherapy versus postoperative chemoradiotherapy Dr

TRANSLATIONAL ONCOLOGY

08:30 - 09:30 TRANSLATIONAL ONCOLOGY SYMPOSIUM Moderators: Dr. Juan Fernando García García MD Anderson Cancer Center Madrid, Spain Dr. Gema Moreno MD Anderson Cancer Center Madrid, Spain

08:30 - 08:50 Detection of cancer stem cells in epithelial tumors and their utility in personalised medicine platforms

Dr. Bruno Sainz Universidad Autónoma Madrid, Spain

08:50 - 09:10 Precursor lesions in PDAC development: consensus and controversies

Dr. Francisco X. Real Centro Nacional de Investigaciones Oncológicas, CNIO, Madrid, Spain

09:10 - 09:30 Discussion

ESOPHAGOGASTRIC

09:30 - 11:00 MULTIDISCIPLINARY SCIENTIFIC SYMPOSIUM Gastric cancer Moderators: Dr. Carmelo Loinaz Hospital Univ. 12 de Octubre, Madrid, Spain Dr. Ignacio Juez MD Anderson Cancer Center Madrid, Spain

09:30 - 09:50 Multimodality treatment of locally advanced gastric cancer: perioperative chemotherapy versus postoperative chemoradiotherapy

Dr. Ismael Díez del Val Hospital Universitario de Basurto, Bilbao, Spain

09:50 - 10:10 What is the role of radiation in gastric cancer: neoadjuvant or adjuvant?

Dr. Felipe A. Calvo Hospital Gral. Univ. Gregorio Marañón, Madrid, Spain

Friday, Decem

ber 1st, 2017

Page 10: 1stMD ANDERSON INTERNATIONAL MEETING IN Gastrointestinal … MD... · 2019. 7. 16. · advanced gastric cancer: perioperative chemotherapy versus postoperative chemoradiotherapy Dr

10:10 - 10:30 Systemic chemotherapy for metastatic gastric cancer. New trends

Dr. Javier Gallego Plazas Hospital Universitario de Elche, Alicante, Spain

10:30 - 11:00 Discussion

11:00 - 11:30 KEYNOTE LECTURE

11:00 - 11:20 Current management of esophageal cancer Dr. Stephen G. Swisher The University of Texas MD Anderson Cancer Center, Houston, USA

11:20 - 11:30 Discussion

11:30 - 12:00 Coffee break

12:00 - 12:45 DEBATE HIPEC has a role in gastric cancer

Moderator: Dr. Santiago González-Moreno MD Anderson Cancer Center Madrid, Spain

12:00 - 12:10 Introduction and voting

12:10 - 12:20 Pro Dr. Brian D. Badgwell The University of Texas MD Anderson Cancer Center, Houston, USA

12:20 - 12:30 Against Dr. Carlos Gómez Hospital Univ. 12 de Octubre, Madrid, Spain

12:30 - 12:40 Discussion

12:40 - 12:45 Voting after debate

Frid

ay, D

ecem

ber 1

st, 2

017

Page 11: 1stMD ANDERSON INTERNATIONAL MEETING IN Gastrointestinal … MD... · 2019. 7. 16. · advanced gastric cancer: perioperative chemotherapy versus postoperative chemoradiotherapy Dr

12:45 - 13:45 MULTIDISCIPLINARY TUMOR BOARD Moderator: Dr. Carmelo Loinaz Hospital Univ. 12 de Octubre, Madrid, Spain

PANEL:Surgical Oncology Dr. Stephen G. Swisher

The University of Texas MD Anderson Cancer Center, Houston, USASurgical Oncology Dr. Brian D. Badgwell

The University of Texas MD Anderson Cancer Center, Houston, USAMedical Oncology Dr. Ignacio Juez

MD Anderson Cancer Center Madrid, SpainMedical Oncology Dr. Carlos Gómez

Hospital Univ. 12 de Octubre, Madrid, SpainRadiation Oncology Dr. Cristina Garrán

MD Anderson Cancer Center Madrid, Spain

PRESENTERS:

12:45 - 13:05 Esophagogastric tumor clinical case 1: EGJ cancer neoadjuvant therapy case

13:05 - 13:25 Esophagogastric tumor clinical case 2: Radical radiation in esophageal scc and rescue surgery

13:25 - 13:45 Esophagogastric tumor clinical case 3: Gastric cancer carcinomatosis case

13:45 - 14:00 CLOSING REMARKS Dr. Santiago González-Moreno MD Anderson Cancer Center Madrid, Spain Dr. Miguel A. Rodríguez-Bigas The University of Texas MD Anderson Cancer Center, Houston, USA

Friday, Decem

ber 1st, 2017

Page 12: 1stMD ANDERSON INTERNATIONAL MEETING IN Gastrointestinal … MD... · 2019. 7. 16. · advanced gastric cancer: perioperative chemotherapy versus postoperative chemoradiotherapy Dr

Venue:Hotel Novotel Madrid CenterCalle de O'Donnell, 53, 28009 Madrid

Language:Simultaneous translation English/Spanish will be provided

Meeting Secretariat:

E-mail: [email protected]:+34 91 372 02 03

Organized by:

Under de auspices of:

Sponsors: